-
Offering expertise for HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage
Project Proposal
The Vascular and Renal Translational Research Group specializes in vascular and kidney diseases, with a particular focus on the progression of chro...
Learn more... -
CUCrowdhelix User
The recording of the A-Tango Project Webinar “Industrial Perspective on Drug Development Challenges for Clinical Trials”
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945096.
Funded by
the European Union -
-
Register for Webinar | A-Tango Project - Industrial Perspective on Drug Development Challenges for Clinical Trials
Industrial Perspective on Drug Development Challenges for Clinical Trials A-Tango Project consortium invites all to join the Liver Health Helix ev...
Learn more...This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945096.
Funded by
the European Union
-
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF
Acute-on-chronic liver failure is associated with severe liver inflammation and poor short-term survival. Therefore, effective treatments are urgen...
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945096.
Funded by
the European Union -
Bicyclic Peptide Inhibitors of the Human Urokinase-Type Plasminogen Activator (HUPA)
Background - Bicyclic peptides are small polypeptides that exhibit properties typical of both monoclonal antibodies (high target specificity and af...
-
Less Toxic Chemotherapy with Palladium
Background - Targeted, efficient and non-toxic anti-cancer drugs: a new class of palladium compounds could be used as innovative chemotherapeutic m...
